Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ameresco (AMRC) Free Cash Flow (2016 - 2025)

Ameresco (AMRC) has disclosed Free Cash Flow for 15 consecutive years, with $79.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Free Cash Flow rose 29.5% to $79.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$382.6 million, a 1496.66% decrease, with the full-year FY2024 number at -$299.4 million, down 101.78% from a year prior.
  • Free Cash Flow was $79.0 million for Q3 2025 at Ameresco, up from $19.5 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $165.2 million in Q3 2023 to a low of -$344.9 million in Q4 2024.
  • A 5-year average of -$66.1 million and a median of -$35.3 million in 2024 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: soared 397.19% in 2023, then tumbled 1802.27% in 2024.
  • Ameresco's Free Cash Flow stood at -$198.2 million in 2021, then rose by 24.35% to -$149.9 million in 2022, then skyrocketed by 87.91% to -$18.1 million in 2023, then crashed by 1802.27% to -$344.9 million in 2024, then surged by 122.9% to $79.0 million in 2025.
  • Per Business Quant, the three most recent readings for AMRC's Free Cash Flow are $79.0 million (Q3 2025), $19.5 million (Q2 2025), and -$136.2 million (Q1 2025).